These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15201989)

  • 1. Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells.
    Takeuchi H; Kanzawa T; Kondo Y; Komata T; Hirohata S; Kyo S; Kondo S
    Int J Oncol; 2004 Jul; 25(1):57-63. PubMed ID: 15201989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
    Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S
    Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y; Shen K; He CX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells.
    Komata T; Kondo Y; Kanzawa T; Ito H; Hirohata S; Koga S; Sumiyoshi H; Takakura M; Inoue M; Barna BP; Germano IM; Kyo S; Kondo S
    Hum Gene Ther; 2002 Jun; 13(9):1015-25. PubMed ID: 12067435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.
    Ito H; Aoki H; Kühnel F; Kondo Y; Kubicka S; Wirth T; Iwado E; Iwamaru A; Fujiwara K; Hess KR; Lang FF; Sawaya R; Kondo S
    J Natl Cancer Inst; 2006 May; 98(9):625-36. PubMed ID: 16670388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo].
    You YP; Fu Z; Zhao P; Wang CZ; Liu N; Lu AL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):605-9. PubMed ID: 17160935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
    Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
    Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
    Kong BH; Song Y; Ma DX; Qu X; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Toyota H; Kondo S; Kyo S; Mizuguchi J
    Anticancer Res; 2006; 26(1A):99-105. PubMed ID: 16475685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
    Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
    Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo.
    Koga S; Hirohata S; Kondo Y; Komata T; Takakura M; Inoue M; Kyo S; Kondo S
    Anticancer Res; 2001; 21(3B):1937-43. PubMed ID: 11497281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effect of 2-5A-linked antisense against telomerase RNA and conventional therapies on human malignant glioma cells in vitro and in vivo.
    Iwado E; Daido S; Kondo Y; Kondo S
    Int J Oncol; 2007 Nov; 31(5):1087-95. PubMed ID: 17912434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cloning of human telomerase reverse transcriptase promoter for targeted cancer therapy].
    Li F; Tan XH; Peng XJ; Cai HB; Hu DR
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):207-11. PubMed ID: 15699008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E suppresses telomerase activity in ovarian cancer cells.
    Bermudez Y; Ahmadi S; Lowell NE; Kruk PA
    Cancer Detect Prev; 2007; 31(2):119-28. PubMed ID: 17335992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
    J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Killing effect of Ad.TERT-TRAIL on tumor cell lines and its mechanism].
    Tang YX; Chen Y; Gu JF; Qi R; Zou WG; Jiang LL; Liu XY
    Ai Zheng; 2005 May; 24(5):536-42. PubMed ID: 15890093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of telomerase by human cytomegalovirus.
    Strååt K; Liu C; Rahbar A; Zhu Q; Liu L; Wolmer-Solberg N; Lou F; Liu Z; Shen J; Jia J; Kyo S; Björkholm M; Sjöberg J; Söderberg-Nauclér C; Xu D
    J Natl Cancer Inst; 2009 Apr; 101(7):488-97. PubMed ID: 19318640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effective inhibition of hTERT expression by RNA interference on the radiosensitivity of human laryngeal cancer Hep-2 cell line].
    Qiu HB; Zhou YF; Zhou FX; Xie CH; Luo ZG; Yu HJ; Liu SQ
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):9-13. PubMed ID: 17575685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase as a therapeutic target for malignant gliomas.
    Komata T; Kanzawa T; Kondo Y; Kondo S
    Oncogene; 2002 Jan; 21(4):656-63. PubMed ID: 11850793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.